Acesion Pharma

About:

Acesion Pharma is a developer of medical drugs designed for the treatment of atrial fibrillation.

Website: http://acesionpharma.com

Twitter/X: AcesionPharma

Top Investors: Novo Holdings, Wellcome Trust, Canaan Partners, Alpha Wave Global, Broadview Ventures

Description:

Acesion Pharma is a developer of medical drugs designed for the treatment of atrial fibrillation. The company's medical drugs develop treatments for atrial fibrillation which is the most common type of cardiac arrhythmia by following the concept of inhibiting a type of ion channel in heart cells that is involved in generating the electrical signals that regulate the heart's rhythm, providing consumers with chronic treatment to prevent the recurrence of AF and maintain normal heart rhythm.

Total Funding Amount:

$67.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Copenhagen, Hovedstaden, Denmark

Founded Date:

2011-01-01

Contact Email:

contact(AT)acesionpharma.com

Founders:

Morten Grunnet, Ulrik Sørensen

Number of Employees:

11-50

Last Funding Date:

2023-09-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai